Title : Introduction of everolimus in kidney transplant recipients at a late posttransplant stage.

Pub. Date : 2018 Sep 10

PMID : 30211023






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This minireview focuses on the current knowledge about the introduction of everolimus (EVL), a mammalian target of rapamycin inhibitor, with calcineurin inhibitor (CNI) elimination or minimization in kidney transplant recipients at a late posttransplant stage. Everolimus calcineurin binding protein 1 Homo sapiens
2 This minireview focuses on the current knowledge about the introduction of everolimus (EVL), a mammalian target of rapamycin inhibitor, with calcineurin inhibitor (CNI) elimination or minimization in kidney transplant recipients at a late posttransplant stage. Everolimus calcineurin binding protein 1 Homo sapiens